Breaking News Instant updates and real-time market news.

EPAM

Epam Systems

$570.18 /

-1.115 (-0.20%)

06:25
08/05/21
08/05
06:25
08/05/21
06:25

Epam Systems reports Q2 EPS $2.05, consensus $1.93

Reports Q2 revenue $881.37M, consensus $860.36M. "Our strong second quarter results demonstrated EPAM's ability to quickly adapt to the changing market conditions, accelerating the rate at which we solve our clients' most complex digital transformation and technology modernization challenges," said Arkadiy Dobkin, CEO and president, Epam. "To continue doing that, we plan to further expand our capabilities and our global talent footprint - deepening our customer relationships and diversifying our solutions portfolio - to deliver value for our clients and ourselves."

  • 05

    Aug

EPAM Epam Systems
$570.18 /

-1.115 (-0.20%)

08/03/21 Jefferies
Epam Systems upgraded to Buy at Jefferies ahead of IT Services up cycle
08/03/21 Jefferies
Epam Systems upgraded to Buy from Hold at Jefferies
07/14/21 Citi
Epam Systems price target raised to $620 from $520 at Citi
05/10/21 Barclays
Epam Systems price target raised to $521 from $450 at Barclays

TODAY'S FREE FLY STORIES

Hot Stocks
Matinas BioPharma announces nomination of Kathryn Penkus Corzo to board » 07:11
09/20/21
09/20
07:11
09/20/21
07:11
MTNB

Matinas BioPharma

$1.11 /

-0.045 (-3.90%)

, TAK

Takeda Pharmaceutical

$17.16 /

-0.045 (-0.26%)

Matinas BioPharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTNB Matinas BioPharma
$1.11 /

-0.045 (-3.90%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

MTNB Matinas BioPharma
$1.11 /

-0.045 (-3.90%)

09/13/21 Piper Sandler
Matinas' next steps for MAT2203 'still unclear,' says Piper Sandler
05/11/21 Piper Sandler
Matinas BioPharma downgraded to Neutral from Overweight at Piper Sandler
03/30/21 H.C. Wainwright
Matinas BioPharma price target lowered to $3 from $4 at H.C. Wainwright
02/01/21 Piper Sandler
Matinas trial shows 'robust' serum increass despite miss, says Piper Sandler
TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
MTNB Matinas BioPharma
$1.11 /

-0.045 (-3.90%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

MTNB Matinas BioPharma
$1.11 /

-0.045 (-3.90%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

TAK Takeda Pharmaceutical
$17.16 /

-0.045 (-0.26%)

Hot Stocks
Alvarium Tiedemann to become public through Cartesian Growth combination » 07:10
09/20/21
09/20
07:10
09/20/21
07:10
GLBL

Cartesian Growth

$9.75 /

+0.05 (+0.52%)

Tiedemann Group, Alvarium…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GLBL Cartesian Growth
$9.75 /

+0.05 (+0.52%)

GLBL Cartesian Growth
$9.75 /

+0.05 (+0.52%)

Hot Stocks
RumbleON acquires Jacksonville-based powersports dealer » 07:10
09/20/21
09/20
07:10
09/20/21
07:10
RMBL

RumbleON

$33.30 /

-0.55 (-1.62%)

RumbleOn, announced it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RMBL RumbleON
$33.30 /

-0.55 (-1.62%)

RMBL RumbleON
$33.30 /

-0.55 (-1.62%)

09/14/21 Wedbush
RumbleON initiated with an Outperform at Wedbush
09/02/21 B. Riley
RumbleON initiated with a Buy at B. Riley
09/02/21 Baird
RumbleON initiated with an Outperform at Baird
03/16/21 JMP Securities
RumbleON price target raised to $70 from $51 at JMP Securities
RMBL RumbleON
$33.30 /

-0.55 (-1.62%)

  • 26
    Aug
  • 09
    Apr
RMBL RumbleON
$33.30 /

-0.55 (-1.62%)

Recommendations
Keurig Dr Pepper price target raised to $36 from $35 at Deutsche Bank » 07:10
09/20/21
09/20
07:10
09/20/21
07:10
KDP

Keurig Dr Pepper

$34.91 /

-0.59 (-1.66%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KDP Keurig Dr Pepper
$34.91 /

-0.59 (-1.66%)

KDP Keurig Dr Pepper
$34.91 /

-0.59 (-1.66%)

06/29/21
Fly Intel: Top five analyst upgrades
06/29/21 Wells Fargo
Wells Fargo upgrades Keurig Dr Pepper on carbonated beverage tailwind
06/29/21 Wells Fargo
Keurig Dr Pepper upgraded to Overweight from Equal Weight at Wells Fargo
03/19/21
Fly Intel: Top five analyst upgrades
KDP Keurig Dr Pepper
$34.91 /

-0.59 (-1.66%)

  • 08
    Jun
  • 17
    Nov
KDP Keurig Dr Pepper
$34.91 /

-0.59 (-1.66%)

KDP Keurig Dr Pepper
$34.91 /

-0.59 (-1.66%)

Hot Stocks
CarLotz announces first hub in Georgia » 07:09
09/20/21
09/20
07:09
09/20/21
07:09
LOTZ

CarLotz

$3.95 /

-0.1 (-2.47%)

CarLotz announced it will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LOTZ CarLotz
$3.95 /

-0.1 (-2.47%)

LOTZ CarLotz
$3.95 /

-0.1 (-2.47%)

08/16/21 Deutsche Bank
CarLotz started at Hold amid 'considerable headwinds' at Deutsche Bank
08/16/21 Deutsche Bank
CarLotz initiated with a Hold at Deutsche Bank
08/10/21 William Blair
CarLotz downgraded to Market Perform from Outperform at William Blair
05/26/21 Barrington
CarLotz price target lowered to $16 from $19 at Barrington
LOTZ CarLotz
$3.95 /

-0.1 (-2.47%)

LOTZ CarLotz
$3.95 /

-0.1 (-2.47%)

LOTZ CarLotz
$3.95 /

-0.1 (-2.47%)

Recommendations
Itron price target lowered to $85 from $120 at Argus » 07:09
09/20/21
09/20
07:09
09/20/21
07:09
ITRI

Itron

$78.80 /

+1.08 (+1.39%)

Argus analyst John Eade…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITRI Itron
$78.80 /

+1.08 (+1.39%)

ITRI Itron
$78.80 /

+1.08 (+1.39%)

08/06/21
Fly Intel: Top five analyst downgrades
08/06/21
Fly Intel: Top five analyst upgrades
08/06/21 Canaccord
Itron price target lowered to $87 from $126 at Canaccord
08/06/21 Baird
Itron downgraded to Neutral from Outperform at Baird
ITRI Itron
$78.80 /

+1.08 (+1.39%)

  • 10
    Mar
ITRI Itron
$78.80 /

+1.08 (+1.39%)

Hot Stocks
BioCryst appoints Amy McKee to board of directors » 07:09
09/20/21
09/20
07:09
09/20/21
07:09
BCRX

BioCryst

$15.67 /

+0.45 (+2.96%)

BioCryst Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BCRX BioCryst
$15.67 /

+0.45 (+2.96%)

BCRX BioCryst
$15.67 /

+0.45 (+2.96%)

08/06/21 Jefferies
BioCryst downgraded to Hold from Buy at Jefferies
08/06/21 H.C. Wainwright
BioCryst price target raised to $30 from $18 at H.C. Wainwright
08/05/21 Piper Sandler
BioCryst price target raised to $22 from $18 at Piper Sandler
08/03/21 Cantor Fitzgerald
BioCryst initiated with an Overweight at Cantor Fitzgerald
BCRX BioCryst
$15.67 /

+0.45 (+2.96%)

  • 11
    Aug
BCRX BioCryst
$15.67 /

+0.45 (+2.96%)

BCRX BioCryst
$15.67 /

+0.45 (+2.96%)

Hot Stocks
Innovative Industrial acquires Missouri property, for $1.53M, in lease with CPC » 07:08
09/20/21
09/20
07:08
09/20/21
07:08
IIPR

Innovative Industrial Properties

$232.85 /

-2.865 (-1.22%)

Innovative Industrial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IIPR Innovative Industrial Properties
$232.85 /

-2.865 (-1.22%)

IIPR Innovative Industrial Properties
$232.85 /

-2.865 (-1.22%)

09/08/21 Compass Point
NewLake Capital Partners initiated with a Buy at Compass Point
09/01/21 BTIG
Innovative Industrial Properties price target raised to $290 from $245 at BTIG
08/09/21 Craig-Hallum
Innovative Industrial Properties price target raised to $240 from $175 at Craig-Hallum
08/06/21 Roth Capital
Innovative Industrial Properties price target raised to $245 from $215 at Roth Capital
IIPR Innovative Industrial Properties
$232.85 /

-2.865 (-1.22%)

Initiation
eFfector Therapeutics initiated with a Hold at Stifel » 07:07
09/20/21
09/20
07:07
09/20/21
07:07
EFTR

eFfector Therapeutics

$19.55 /

-0.08 (-0.41%)

Stifel analyst Benjamin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EFTR eFfector Therapeutics
$19.55 /

-0.08 (-0.41%)

EFTR eFfector Therapeutics
$19.55 /

-0.08 (-0.41%)

09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Cantor Fitzgerald
eFfector Therapeutics initiated with an Overweight at Cantor Fitzgerald
09/13/21 Cantor Fitzgerald
eFfector Therapeutics initiated with an Overweight at Cantor Fitzgerald
Hot Stocks
Immunocore presents data on tebentafusp in reducing ctDNA » 07:07
09/20/21
09/20
07:07
09/20/21
07:07
IMCR

Immunocore

$34.46 /

+2.01 (+6.19%)

Immunocore Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMCR Immunocore
$34.46 /

+2.01 (+6.19%)

IMCR Immunocore
$34.46 /

+2.01 (+6.19%)

03/02/21 Jefferies
Immunocore initiated with a Buy at Jefferies
03/02/21 JPMorgan
Immunocore initiated with an Overweight at JPMorgan
03/02/21 Goldman Sachs
Immunocore initiated with a Neutral at Goldman Sachs
IMCR Immunocore
$34.46 /

+2.01 (+6.19%)

  • 05
    Feb
IMCR Immunocore
$34.46 /

+2.01 (+6.19%)

Hot Stocks
Live Oak Acquisition II extends tender offer related to combination with Navitas » 07:06
09/20/21
09/20
07:06
09/20/21
07:06
LOKB

Live Oak Acquisition II

$9.98 /

-0.005 (-0.05%)

Live Oak Acquisition…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LOKB Live Oak Acquisition II
$9.98 /

-0.005 (-0.05%)

LOKB Live Oak Acquisition II
$9.98 /

-0.005 (-0.05%)

09/01/21 Craig-Hallum
Live Oak Acquisition II initiated with a Buy at Craig-Hallum
LOKB Live Oak Acquisition II
$9.98 /

-0.005 (-0.05%)

Hot Stocks
Universal Stainless & Alloy announces base price increase on long products » 07:05
09/20/21
09/20
07:05
09/20/21
07:05
USAP

Universal Stainless & Alloy

$10.77 /

+0.36 (+3.46%)

Universal Stainless &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USAP Universal Stainless & Alloy
$10.77 /

+0.36 (+3.46%)

USAP Universal Stainless & Alloy
$10.77 /

+0.36 (+3.46%)

Hot Stocks
Verastem announces clinical collaboration with Amgen in NSCLC treatment » 07:05
09/20/21
09/20
07:05
09/20/21
07:05
VSTM

Verastem

$2.76 /

+0.06 (+2.23%)

, AMGN

Amgen

$219.52 /

+2.18 (+1.00%)

Verastem (VSTM) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VSTM Verastem
$2.76 /

+0.06 (+2.23%)

AMGN Amgen
$219.52 /

+2.18 (+1.00%)

VSTM Verastem
$2.76 /

+0.06 (+2.23%)

07/01/21 Alliance Global Partners
Verastem initiated with a Buy at Alliance Global Partners
05/24/21 BTIG
Verastem upgraded to Buy from Neutral at BTIG
05/24/21 BTIG
Verastem upgraded to Buy from Neutral at BTIG
AMGN Amgen
$219.52 /

+2.18 (+1.00%)

09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley cuts Amgen to Equal Weight, sees better risk/reward elsewhere
09/07/21 Morgan Stanley
Amgen downgraded to Equal Weight from Overweight at Morgan Stanley
08/12/21 Goldman Sachs
Revolution Medicines downgraded to Neutral from Buy at Goldman Sachs
VSTM Verastem
$2.76 /

+0.06 (+2.23%)

AMGN Amgen
$219.52 /

+2.18 (+1.00%)

VSTM Verastem
$2.76 /

+0.06 (+2.23%)

AMGN Amgen
$219.52 /

+2.18 (+1.00%)

AMGN Amgen
$219.52 /

+2.18 (+1.00%)

Hot Stocks
Miromatrix Medical added to Russell Microcap Index » 07:05
09/20/21
09/20
07:05
09/20/21
07:05
MIRO

Miromatrix Medical

$7.14 /

-0.61 (-7.87%)

Miromatrix Medical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MIRO Miromatrix Medical
$7.14 /

-0.61 (-7.87%)

MIRO Miromatrix Medical
$7.14 /

-0.61 (-7.87%)

07/19/21 Craig-Hallum
Craig-Hallum bullish on Miromatrix Medical, initiates with a Buy
07/19/21 Craig-Hallum
Miromatrix Medical initiated with a Buy at Craig-Hallum
  • 24
    Jun
MIRO Miromatrix Medical
$7.14 /

-0.61 (-7.87%)

Hot Stocks
Farmland Partners shares impact from Hurricanes Ida, Nicholas » 07:04
09/20/21
09/20
07:04
09/20/21
07:04
FPI

Farmland Partners

$12.47 /

-0.21 (-1.66%)

Farmland Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FPI Farmland Partners
$12.47 /

-0.21 (-1.66%)

FPI Farmland Partners
$12.47 /

-0.21 (-1.66%)

03/26/21 B. Riley Securities
Farmland Partners price target raised to $11.50 from $8.50 at B. Riley
11/25/20 B. Riley Securities
Farmland Partners price target raised to $8.50 from $7 at B. Riley Securities
FPI Farmland Partners
$12.47 /

-0.21 (-1.66%)

Hot Stocks
Landos, Icahn School of Medicine to collaborate on Omilancor Phase 2 study » 07:04
09/20/21
09/20
07:04
09/20/21
07:04
LABP

Landos Biopharma

$15.41 /

+0.14 (+0.92%)

Landos Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LABP Landos Biopharma
$15.41 /

+0.14 (+0.92%)

LABP Landos Biopharma
$15.41 /

+0.14 (+0.92%)

03/01/21 Jefferies
Landos Biopharma initiated with a Buy at Jefferies
03/01/21 JPMorgan
Landos Biopharma initiated with a Neutral at JPMorgan
03/01/21 Raymond James
Landos Biopharma initiated with an Outperform at Raymond James
03/01/21 SVB Leerink
Landos Biopharma initiated with an Outperform at SVB Leerink
LABP Landos Biopharma
$15.41 /

+0.14 (+0.92%)

  • 04
    Feb
Initiation
Clarus Therapeutics initiated with an Overweight at Cantor Fitzgerald » 07:03
09/20/21
09/20
07:03
09/20/21
07:03
CRXT

Clarus Therapeutics

$8.78 /

+0.98 (+12.56%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRXT Clarus Therapeutics
$8.78 /

+0.98 (+12.56%)

CRXT Clarus Therapeutics
$8.78 /

+0.98 (+12.56%)

06:05 Today Cantor Fitzgerald
Clarus Therapeutics initiated with an Overweight at Cantor Fitzgerald
Hot Stocks
Plus Products announces launch of Dual Action Sleep Gummies » 07:02
09/20/21
09/20
07:02
09/20/21
07:02
PLPRF

Plus Products

/

+

Plus Products announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLPRF Plus Products
/

+

PLPRF Plus Products
/

+

10/15/20 Roth Capital
TFF Pharmaceuticals price target raised to $23 from $18 at Roth Capital
PLPRF Plus Products
/

+

Upgrade
Tryg upgraded to Neutral from Underperform at Credit Suisse » 07:02
09/20/21
09/20
07:02
09/20/21
07:02
TGVSF

Tryg

$23.82 /

+ (+0.00%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGVSF Tryg
$23.82 /

+ (+0.00%)

06/18/21 Morgan Stanley
Tryg resumed with an Equal Weight at Morgan Stanley
03/16/21 Citi
Tryg upgraded to Buy from Neutral at Citi
Hot Stocks
Bristol-Myers: FDA accepts priority review for relatlimab/nivolumab BLA » 07:01
09/20/21
09/20
07:01
09/20/21
07:01
BMY

Bristol-Myers

$61.32 /

+0.1 (+0.16%)

Bristol Myers Squibb…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

06:31 Today Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

BMY Bristol-Myers
$61.32 /

+0.1 (+0.16%)

Recommendations
Las Vegas Sands price target lowered to $42 from $53 at Morgan Stanley » 07:00
09/20/21
09/20
07:00
09/20/21
07:00
LVS

Las Vegas Sands

$38.17 /

+0.66 (+1.76%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

09/17/21
Fly Intel: Top five analyst downgrades
09/17/21 Jefferies
Jefferies downgrades Las Vegas Sands on 'growth uncertainty' in Macau
09/17/21 Jefferies
Las Vegas Sands downgraded to Hold from Buy at Jefferies
09/16/21 JPMorgan
JPMorgan downgrades Las Vegas Sands on Macau uncertainty
LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

Recommendations
Morgan Stanley cuts Wynn Resorts price target to $113, but says 'worth the risk' » 06:59
09/20/21
09/20
06:59
09/20/21
06:59
WYNN

Wynn Resorts

$83.30 /

-1.095 (-1.30%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

09/17/21
Fly Intel: Top five analyst downgrades
09/17/21 Argus
Wynn Resorts downgraded to Hold from Buy at Argus
09/17/21 Argus
Wynn Resorts downgraded to Hold from Buy at Argus
09/16/21 JPMorgan
Wynn Resorts downgraded on Macau uncertainty at JPMorgan
WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

  • 09
    Feb
WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

Upgrade
Methanex upgraded to Outperform from Sector Perform at Scotiabank » 06:58
09/20/21
09/20
06:58
09/20/21
06:58
MEOH

Methanex

$42.90 /

+1.3 (+3.13%)

Scotiabank analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MEOH Methanex
$42.90 /

+1.3 (+3.13%)

MEOH Methanex
$42.90 /

+1.3 (+3.13%)

09/13/21 Piper Sandler
Methanex initiated with a Neutral at Piper Sandler
09/07/21 Barclays
Methanex upgraded to Overweight from Equal Weight at Barclays
09/01/21 RBC Capital
Methanex to generate strong cash flows in 2021-22, says RBC Capital
07/19/21 TD Securities
Methanex price target raised to $54 from $51 at TD Securities
MEOH Methanex
$42.90 /

+1.3 (+3.13%)

Hot Stocks
PyroGenesis joins two FTSE Russell Indexes » 06:58
09/20/21
09/20
06:58
09/20/21
06:58
PYR

PyroGenesis

$4.42 /

+0.1 (+2.31%)

PyroGenesis Canada is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PYR PyroGenesis
$4.42 /

+0.1 (+2.31%)

PYR PyroGenesis
$4.42 /

+0.1 (+2.31%)

PYR PyroGenesis
$4.42 /

+0.1 (+2.31%)

PYR PyroGenesis
$4.42 /

+0.1 (+2.31%)

Hot Stocks
Materion to acquire H.C. Starck's Electronic Materials portfolio » 06:57
09/20/21
09/20
06:57
09/20/21
06:57
MTRN

Materion

$71.29 /

+1.01 (+1.44%)

Materion Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTRN Materion
$71.29 /

+1.01 (+1.44%)

MTRN Materion
$71.29 /

+1.01 (+1.44%)

08/09/21 KeyBanc
Materion downgraded to Sector Weight from Overweight at KeyBanc
05/06/21 Sidoti
Materion reinstated with a Buy at Sidoti
01/26/21 KeyBanc
Materion price target raised to $80 from $68 at KeyBanc
MTRN Materion
$71.29 /

+1.01 (+1.44%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.